关于功能性便秘与焦虑或抑郁症的研究:一个图书统计分析
Xiaoqin Li1, Qiang Lei2, Jiao Xie3
1Clinical Medicine College, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China.
Frontiers in psychiatry
|July 3, 2025
概括
这项文献计量研究分析了与焦虑或抑郁相关的功能性便秘 (FC) 的研究,揭示了日益增长的出版趋势和关键研究领域. 未来的研究应该探索病因学,大脑-肠轴,以及基于证据的治疗方法,如便微生物群移植.
科学领域:
- 胃肠病学 胃肠病学
- 精神病学是一个精神病学.
- 图书统计学 图书统计学
背景情况:
- 与焦虑或抑郁同时发生的功能性便秘 (FC) 是一个公认的现象.
- 尽管进行了广泛的调查,但该主题的文献计量研究仍然缺乏.
- 本研究通过分析FC的现状和趋势与焦虑或抑郁研究来解决研究缺口.
研究的目的:
- 对与焦虑或抑郁相关的功能性便秘 (FC) 的研究进行文献分析.
- 确定研究趋势,主要贡献者和兴趣的新兴领域.
- 为这个跨学科领域的未来研究方向提供见解.
主要方法:
- 从2003年到2024年对出版物的图书统计分析.
- 数据来源于科学网络核心集合的数据.
- 使用CiteSpace和VOSviewer进行分析,以查看出版趋势,作者贡献,国家/机构产出以及关键词的共同出现.
主要成果:
- 从2003年到2024年,年度出版物的显著上升趋势表明研究兴趣日益增长.
- 总共有427篇出版物被确定,主要是原创研究文章 (83.61%).
- 美国在出版方面处于领先地位,哈佛大学是主要机构,米歇尔·布丘沙是多产的作家.
结论:
- 未来的研究应该专注于与焦虑/抑郁相关的FC的病因和发病,包括阿片类药物的作用和脑肠轴.
- 临床研究应优先考虑基于证据的医学,随机对照试验和强大的元分析.
- 新的治疗策略,如便微生物群移植和生物反疗法,需要进行临床探索.
相关概念视频
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
255
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
255
01:18Anxiety: Overview
374
Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
374
01:30Generalized Anxiety Disorder
214
Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...
214
01:25Assessment of the Rectum and Anus
415
Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
415
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
316
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
316
01:21Drugs for Treatment of Constipation-Predominant IBS
351
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
351